New Lifeclinics INC

New Lifeclinics INC was paid $6.50M by Medicaid between Jan 2018 and Jun 2022, across 19 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 21% of everything it billed.

Compared with peers

Next to other Addiction Medicine (Family Medicine) Physician providers in West Virginia

Rank by total paid#2 of 12

Median peer was paid$1.16M

This provider vs. median5.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	50,611	$5.07M
2019	19,578	$1.09M
2020	3,599	$205K
2021	2,871	$109K
2022	582	$30K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	21%	5,547	2,126	$1.34M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	16%	16,256	5,999	$1.05M
82075		13%	14,134	5,291	$851K
90834	Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient	9.7%	5,954	2,826	$629K
80305		8.6%	8,377	3,251	$560K
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	7.9%	3,594	1,941	$515K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	7.2%	6,117	2,275	$465K
81025		6.3%	7,797	2,907	$411K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	3.4%	1,351	742	$224K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	2.9%	3,028	1,177	$186K
90853	Group psychotherapy (other than of a multiple-family group)	1.4%	3,250	1,730	$88K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	338	198	$62K

7 more codes

90837	Psychotherapy session, about an hour	<1%	435	$48K
99214	Doctor's office visit, returning patient (more involved)	<1%	526	$40K
90836		<1%	342	$23K
99406		<1%	54	$6K
99203	Doctor's office visit, new patient (routine)	<1%	60	$6K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	60	$3K
99204	Doctor's office visit, new patient (more involved)	<1%	21	$2K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOWEN, JAMES (OWNER)

Same official

Other billing entities under BOWEN, JAMES

Full network →

Provider	Location	Paid
Mountaineer Laboratories LLC	Point Pleasant, WV	$3.71M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.